Robert J. Ligthelm
Robert J. Ligthelm publishes mostly in Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Surgery, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
- World rank
- #3,737,244 of 7,710,434 ranked researchers
- Rank in Netherlands
- #72,827 of 107,149
- Works
- 55
- Citations
- 1.5k
- Citations per work
- 27.5
What does Robert J. Ligthelm research?
Robert J. Ligthelm's work is mostly in Medicine (70%), Immunology and Microbiology (4%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3869.7%
- Medicine3869.7%
- Everything else1323.8%
- Life Sciences46.5%
- 1Endocrinology, Diabetes and Metabolism49% of their works
- 2Public Health, Environmental and Occupational Health13% of their works
- 3Surgery4% of their works
- 4Parasitology4% of their works
- 5Infectious Diseases3% of their works
- 6Genetics3% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Travel-related health issues
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Malaria Research and Control
- Pancreatic function and diabetes
- Diabetes and associated disorders
Which keywords describe Robert J. Ligthelm's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Type 1 Diabetes, Continuous Glucose Monitoring, Hypoglycemia and Cardiovascular Outcomes.
- Autoimmunity
- Pancreatic Islets
- Artemisinin Resistance
- Insulin Resistance
- Travelers' Diarrhea
- Hyperglycemia
- Diabetes Mellitus
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Type 1 Diabetes
- Hypoglycemia
- Type 2 Diabetes
- Critical Care
- Mass Gatherings
- Epidemiology
- Metabolic Syndrome
- Plasmodium falciparum
- ß-Cell Dysfunction
- Genetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Glycemic Control653 topics
- Insulin Therapy653 topics
- Cardiovascular Disease362 topics
- Diabetes362 topics
- Type 1 Diabetes332 topics
- Continuous Glucose Monitoring291 topic
- Hypoglycemia291 topic
- Cardiovascular Outcomes211 topic
- Type 2 Diabetes211 topic
- Diabetes Mellitus202 topics
- Critical Care151 topic
- Hyperglycemia151 topic
- Mass Gatherings141 topic
- Travelers' Diarrhea141 topic
- Epidemiology102 topics
- Insulin Resistance71 topic
- Metabolic Syndrome71 topic
- Artemisinin Resistance61 topic
- Plasmodium falciparum61 topic
- Pancreatic Islets51 topic
- ß-Cell Dysfunction51 topic
- Autoimmunity41 topic
- Genetics41 topic
Where does Robert J. Ligthelm work?
Robert J. Ligthelm's main affiliation in the publication record is Havenziekenhuis Rotterdam, Netherlands.
How many publications and citations does Robert J. Ligthelm have?
OpenAlex counts 55 works and 1,513 citations for Robert J. Ligthelm, an h-index of 23, ranking #3,737,244 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert J. Ligthelm. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.